mebendazole has been researched along with albendazole sulfoxide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Guo, HF; Jiao, PY; Xiao, SH; You, JQ | 1 |
| Chai, JJ; Jiao, PY; Wang, MJ; Xiao, SH; Yang, B; You, JQ | 1 |
| Guo, HF; Jiao, PY; Jiao, W; Xiao, SH; Yang, YQ; You, JQ; Zhang, CW | 1 |
| Hurtado, M; Jung, H; Medina, MT; Sotelo, J | 1 |
| Dieckmann-Schuppert, A; Franklin, RM | 1 |
| Chai, JJ; Jiao, W; Shen, BG; Xiao, SH; Yang, YQ; You, JQ | 1 |
| Alonso-Villalobos, P; Martinez-Grueiro, MM | 1 |
| Cuesta-Bandera, C; Daniel-Mwuambete, K; Ponce-Gordo, F; Torrado, J; Torrado, S | 1 |
| Cuesta-Bandera, C; Daniel-Mwambete, K; Ponce-Gordo, F; Torrado, JJ; Torrado, S | 1 |
| Cvilink, V; Ketola, RA; Kostiainen, R; Lamka, J; Skálová, L; Szotáková, B | 1 |
| Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P | 1 |
| Cowan, N; Keiser, J; Meier, C; Neodo, A | 1 |
| Dimunová, D; Lamka, J; Matoušková, P; Nguyen, LT; Sečkařová, A; Skálová, L; Stuchlíková, LR; Szotáková, B; Várady, M; Vokřál, I | 1 |
14 other study(ies) available for mebendazole and albendazole sulfoxide
| Article | Year |
|---|---|
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
[Uptake and release of mebendazole, albendazole and albendazole sulfoxide by secondary cysts of Echinococcus granulosus in vitro].
Topics: Albendazole; Animals; Anthelmintics; Echinococcus; Mebendazole; Mice | 1991 |
[Pharmacokinetics of four benzimidazoles administered intragastrically to mice infected with secondary cysts of Echinococcus granulosus].
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Female; Mebendazole; Mice; Stomach | 1991 |
[Effect of mebendazole, albendazole and albendazole sulfoxide on glycogen contents of Echinococcus granulosus cysts in infected mice].
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Echinococcus; Female; Glycogen; Mebendazole; Mice | 1990 |
Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid.
Topics: Albendazole; Chromatography, High Pressure Liquid; Humans; Mebendazole | 1989 |
Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro.
Topics: Actins; Albendazole; Animals; Anthelmintics; Antimalarials; Antineoplastic Agents; Benzimidazoles; Cytochalasin B; Cytoskeletal Proteins; Demecolcine; Dioxolanes; Drug Resistance; Erythrocytes; Humans; Mebendazole; Nocodazole; Plasmodium falciparum; Tubulin; Vinblastine; Vincristine | 1989 |
Effects of benzimidazole compounds on mice infected with secondary cysts of Echinococcus granulosus.
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis; Echinococcus; Female; In Vitro Techniques; Mebendazole; Mice | 1994 |
The in vitro secretion of acetylcholinesterase by adult stages of Heligmosomoides polygyrus: the effects of broad-spectrum anthelmintics.
Topics: Acetylcholinesterase; Albendazole; Animals; Anthelmintics; Colorimetry; Culture Media; Drug Evaluation, Preclinical; Female; Fetal Blood; Ivermectin; Levamisole; Male; Mebendazole; Mice; Morantel; Nematospiroides dubius; Serum Albumin, Bovine; Strongylida Infections | 2000 |
Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Biological Availability; Dose-Response Relationship, Drug; Echinococcosis; Echinococcus; Female; Mebendazole; Mice; Treatment Outcome | 2003 |
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Linear Models; Mebendazole; Mice; Povidone; Solubility; Time Factors | 2004 |
LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, Liquid; Haemonchus; Mass Spectrometry; Mebendazole; Oxidation-Reduction | 2008 |
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators | 2013 |
Exposure of Heligmosomoides polygyrus and Trichuris muris to albendazole, albendazole sulfoxide, mebendazole and oxantel pamoate in vitro and in vivo to elucidate the pathway of drug entry into these gastrointestinal nematodes.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Gastrointestinal Tract; Injections, Intraperitoneal; Mebendazole; Mice; Nematospiroides dubius; Plasma; Pyrantel Pamoate; Trichuris | 2017 |
Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites.
Topics: Albendazole; Animals; Anthelmintics; Biochemical Phenomena; Biotransformation; Drug Resistance; Female; Haemonchiasis; Haemonchus; Male; Mebendazole; Sex Factors; Sheep; Sheep Diseases; Tandem Mass Spectrometry | 2018 |